1. Home
  2. PNTG vs NRIX Comparison

PNTG vs NRIX Comparison

Compare PNTG & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PNTG
  • NRIX
  • Stock Information
  • Founded
  • PNTG 2019
  • NRIX 2009
  • Country
  • PNTG United States
  • NRIX United States
  • Employees
  • PNTG N/A
  • NRIX N/A
  • Industry
  • PNTG Medical/Nursing Services
  • NRIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PNTG Health Care
  • NRIX Health Care
  • Exchange
  • PNTG Nasdaq
  • NRIX Nasdaq
  • Market Cap
  • PNTG 805.7M
  • NRIX 908.0M
  • IPO Year
  • PNTG N/A
  • NRIX 2020
  • Fundamental
  • Price
  • PNTG $26.18
  • NRIX $13.16
  • Analyst Decision
  • PNTG Buy
  • NRIX Strong Buy
  • Analyst Count
  • PNTG 6
  • NRIX 16
  • Target Price
  • PNTG $35.17
  • NRIX $30.44
  • AVG Volume (30 Days)
  • PNTG 291.3K
  • NRIX 727.2K
  • Earning Date
  • PNTG 08-05-2025
  • NRIX 07-09-2025
  • Dividend Yield
  • PNTG N/A
  • NRIX N/A
  • EPS Growth
  • PNTG 40.99
  • NRIX N/A
  • EPS
  • PNTG 0.76
  • NRIX N/A
  • Revenue
  • PNTG $748,167,000.00
  • NRIX $56,417,000.00
  • Revenue This Year
  • PNTG $25.01
  • NRIX $16.69
  • Revenue Next Year
  • PNTG $8.19
  • NRIX N/A
  • P/E Ratio
  • PNTG $34.40
  • NRIX N/A
  • Revenue Growth
  • PNTG 30.04
  • NRIX N/A
  • 52 Week Low
  • PNTG $21.18
  • NRIX $8.18
  • 52 Week High
  • PNTG $37.13
  • NRIX $29.56
  • Technical
  • Relative Strength Index (RSI)
  • PNTG 37.30
  • NRIX 59.54
  • Support Level
  • PNTG $25.53
  • NRIX $12.10
  • Resistance Level
  • PNTG $26.53
  • NRIX $12.90
  • Average True Range (ATR)
  • PNTG 1.07
  • NRIX 0.65
  • MACD
  • PNTG -0.36
  • NRIX 0.03
  • Stochastic Oscillator
  • PNTG 11.51
  • NRIX 82.66

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Share on Social Networks: